Hepatitis c virus vaccine composition
OwnerTakaji Wakita, Masaki Moriyama +2inventors
InventorsTakaji Wakita, Masaki Moriyama, Daisuke Akazawa, Noriko Nakamura
Life of this patent
Estimating the term…
Loading patent…
OwnerTakaji Wakita, Masaki Moriyama +2inventors
InventorsTakaji Wakita, Masaki Moriyama, Daisuke Akazawa, Noriko Nakamura
Estimating the term…
A combination of an HCV antigen for inducing an antibody having the activity of inhibiting HCV infection and an optimum adjuvant is discovered, so as to provide an effective HCV vaccine composition. The hepatitis C virus vaccine composition comprises: inactivated viral particles obtained by inactivating infectious hepatitis C virus particles prepared from hepatitis C virus genome that contains sequences encoding NS3 protein, NS4A protein, NS4B protein, NS5A protein and NS5B protein derived from hepatitis C virus JFH1 strain; an oligonucleotide containing unmethylated CpG, according to SEQ ID NO: 5 in the sequence listing; and aluminium hydroxide.
A hepatitis C virus vaccine composition, comprising:
A hepatitis C virus vaccine composition, comprising:
Dependencies are inferred from the claim text.